Zhejiang Shengda Pharm (603079) — Tangible Net Worth Ratio
Zhejiang Shengda Pharm (603079) has a Tangible Net Worth Ratio of 86.4% as of March 2026. This metric is calculated by deducting intangible assets (CN¥221.25 Million) from net assets (CN¥1.63 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 603079 net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Zhejiang Shengda Pharm Tangible Net Worth Ratio (2012–2025)
This chart shows how Zhejiang Shengda Pharm's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 86.4%, reflecting net assets of CN¥1.63 Billion with intangible assets of CN¥221.25 Million CNY. Also explore net asset momentum of Zhejiang Shengda Pharm to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Zhejiang Shengda Pharm (2012–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Zhejiang Shengda Pharm from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 603079 market cap overview.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 86.2% | CN¥1.61 Billion | CN¥222.94 Million | CN¥2.20 Billion | ▲ +3.8 pp |
| 2024 | 82.4% | CN¥1.28 Billion | CN¥225.58 Million | CN¥1.79 Billion | ▲ +0.7 pp |
| 2023 | 81.7% | CN¥1.27 Billion | CN¥231.82 Million | CN¥1.72 Billion | ▼ -2.0 pp |
| 2022 | 83.8% | CN¥1.34 Billion | CN¥218.20 Million | CN¥1.66 Billion | ▼ -4.6 pp |
| 2021 | 88.3% | CN¥1.34 Billion | CN¥156.09 Million | CN¥1.76 Billion | ▲ +0.8 pp |
| 2020 | 87.5% | CN¥1.33 Billion | CN¥165.59 Million | CN¥1.70 Billion | ▲ +6.8 pp |
| 2019 | 80.7% | CN¥911.71 Million | CN¥175.60 Million | CN¥1.53 Billion | ▼ -3.7 pp |
| 2018 | 84.5% | CN¥828.42 Million | CN¥128.82 Million | CN¥1.25 Billion | ▲ +0.0 pp |
| 2017 | 84.4% | CN¥768.71 Million | CN¥119.90 Million | CN¥985.98 Million | ▲ +13.5 pp |
| 2016 | 70.9% | CN¥440.02 Million | CN¥128.02 Million | CN¥741.37 Million | ▲ +1.5 pp |
| 2015 | 69.4% | CN¥439.09 Million | CN¥134.34 Million | CN¥624.13 Million | ▲ +3.9 pp |
| 2014 | 65.5% | CN¥324.87 Million | CN¥112.06 Million | CN¥548.27 Million | ▲ +7.8 pp |
| 2013 | 57.7% | CN¥281.09 Million | CN¥118.91 Million | CN¥505.09 Million | ▲ +26.0 pp |
| 2012 | 31.7% | CN¥185.99 Million | CN¥127.03 Million | CN¥507.42 Million | — |